Orodispersible lozenges containing a combination of Lactobacillus reuteri DSM 17938 and Lactobacillus reuteri ATCC PTA 5289 and normal gum function: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006

Following an application from BioGaia AB submitted for authorisation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006 via the Competent Authority of Sweden, the EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) was asked to deliver an opinion on the scientific...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:EFSA J
Hoofdauteurs: Turck, Dominique, Castenmiller, Jacqueline, De Henauw, Stefaan, Ildico Hirsch‐Ernst, Karen, Kearney, John, Knutsen, Helle Katrine, Maciuk, Alexandre, Mangelsdorf, Inge, McArdle, Harry J, Naska, Androniki, Pelaez, Carmen, Pentieva, Kristina, Thies, Frank, Tsabouri, Sophia, Vinceti, Marco, Bresson, Jean‐Louis, Sanz, Yolanda, Siani, Alfonso
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: John Wiley and Sons Inc. 2020
Onderwerpen:
Scientific Opinion
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7447865/
https://ncbi.nlm.nih.gov/pubmed/32874242
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2903/j.efsa.2020.6004
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items